Advertisement

Adjuvant radiotherapy for Merkel cell carcinoma: A systematic review and meta-analysis

Published:February 28, 2019DOI:https://doi.org/10.1016/j.radonc.2019.02.015

      Highlights

      • Merkel cell carcinoma (MCC) is a cutaneous malignancy with high risk of relapse.
      • The main treatment is surgery plus or minus adjuvant radiotherapy (RT).
      • We performed a systematic review and meta-analysis of the benefits of adjuvant RT.
      • There was a significant increase in OS with adjuvant RT (HR = 0.81, P < 0.001).
      • We found that adjuvant RT may improve locoregional control and survival in MCC.

      Abstract

      Merkel cell carcinoma (MCC) is a rare and aggressive cutaneous malignancy with a high propensity for local recurrence and regional and distant metastases. The main treatment is surgery with narrow excision margins and draining nodes, plus or minus adjuvant radiotherapy (RT) on the surgical bed and/or lymph nodes. We performed a systematic review and meta-analysis of the benefits of adjuvant RT in MCC treatment. PubMed, EMBASE, and the Cochrane Library were systematically searched to identify relevant studies published before September 2018. Prospective trials and retrospective series comparing adjuvant RT vs. no RT in resected primary MCCs were included. Primary endpoint was to evaluate the outcomes of MCC patients who received adjuvant RT in term of overall survival (OS) and disease-free survival (DFS). Hazard ratios (HRs) for OS and DFS were aggregated according to a fixed or random effect model. Secondary endpoints were local, locoregional, and distant DFS.
      A total of 17,179 MCCs across 29 studies were analysed. There was a significant difference in OS between the RT and no RT arms (HR = 0.81, 95%CI 0.75–0.86, P < 0.001). There was also a significant difference in DFS in favour of adjuvant RT (HR = 0.45, 95%CI 0.32–0.62, P < 0.001). Adjuvant RT improved locoregional DFS and local DFS but not distant DFS (HR = 0.3, 95%CI 0.22–0.42; HR = 0.21, 95%CI 0.14–0.33, and HR = 0.79, 95%CI 0.49–1.14, respectively). Meta-regression analysis showed that high Newcastle–Ottawa scale scores, stage I–II MCCs, shorter follow-up durations, size >2 cm, and being of a younger age were associated with increased OS. This systematic review and meta-analysis suggests a survival and DFS benefit for postoperative radiation of MCCs. Intermediate stage MCCs derive the maximum benefit with local and regional relapses reduced by 80% and 70%, respectively. Conversely, distant metastases were not significantly prevented.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Radiotherapy and Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Foote M.
        • Veness M.
        • Zarate D.
        • Poulsen M.
        Merkel cell carcinoma: the prognostic implications of an occult primary in stage IIIB (nodal) disease.
        J Am Acad Dermatol. 2012; 67: 395-399https://doi.org/10.1016/j.jaad.2011.09.009
        • Boyer J.D.
        • Zitelli J.A.
        • Brodland D.G.
        • D’Angelo G.
        Local control of primary Merkel cell carcinoma: review of 45 cases treated with Mohs micrographic surgery with and without adjuvant radiation.
        J Am Acad Dermatol. 2002; 47: 885-892https://doi.org/10.1067/mjd.2002.125083
        • Sexton K.W.
        • Poteet S.P.
        • Hill J.B.
        • et al.
        Adjuvant radiation therapy increases disease-free survival in stage IB Merkel cell carcinoma.
        Ann Plast Surg. 2014; 73: 531-534https://doi.org/10.1097/SAP.0b013e31827f4c58
        • Hasan S.
        • Liu L.
        • Triplet J.
        • Li Z.
        • Mansur D.
        The role of postoperative radiation and chemoradiation in Merkel cell carcinoma: a systematic review of the literature.
        Front Oncol. 2013; 3: 1-10https://doi.org/10.3389/fonc.2013.00276
        • Kim J.A.
        • Choi A.H.
        Effect of radiation therapy on survival in patients with resected merkel cell carcinoma: a propensity score surveillance, epidemiology, and end results database analysis.
        JAMA Dermatol. 2013; 149: 831-838https://doi.org/10.1001/jamadermatol.2013.409
        • Strom T.
        • Carr M.
        • Zager J.S.
        • et al.
        Radiation therapy is associated with improved outcomes in Merkel cell carcinoma.
        Ann Surg Oncol. 2016; 23: 3572-3578https://doi.org/10.1245/s10434-016-5293-1
        • Servy A.
        • Maubec E.
        • Sugier P.E.
        • et al.
        Merkel cell carcinoma: value of sentinel lymph-node status and adjuvant radiation therapy.
        Ann Oncol. 2016; 27: 914-919https://doi.org/10.1093/annonc/mdw035
        • Jadad A.R.
        • Moore R.A.
        • Carroll D.
        • et al.
        Assessing the quality of reports of randomized clinical trials: is blinding necessary?.
        Control Clin Trials. 1996; 17: 1-12https://doi.org/10.1016/0197-2456(95)00134-4
      1. Wells GA, Shea B, O’connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 13 Aug 2014. Ottawa Hosp Res Inst. 2014.

        • Higgins J.P.T.
        • Thompson S.G.
        • Deeks J.J.
        • Altman D.G.
        Measuring inconsistency in meta-analyses.
        BMJ Br Med J. 2003; 327: 557-560https://doi.org/10.1136/bmj.327.7414.557
        • DerSimonian R.
        • Laird N.
        Meta-analysis in clinical trials.
        Control Clin Trials. 1986; 7: 177-188https://doi.org/10.1016/0197-2456(86)90046-2
        • Begg C.B.
        • Mazumdar M.
        Operating characteristics of a bank correlation test for publication bias.
        Biometrics. 1994; 50: 1088-1101https://doi.org/10.2307/2533446
        • Egger M.
        • Smith G.D.
        • Schneider M.
        • Minder C.
        Bias in meta-analysis detected by a simple, graphical test measures of funnel plot asymmetry.
        BMJ. 1997; 315: 629-634https://doi.org/10.1136/bmj.315.7109.629
        • Balakrishnan V.
        • Berry S.
        • Stew B.
        • Sizeland A.
        Benefits of combined modality treatment of Merkel cell carcinoma of the head and neck: single institution experience.
        J Laryngol Otol. 2013; 127: 908-916https://doi.org/10.1017/S0022215113001862
        • Bhatia S.
        • Storer B.E.
        • Iyer J.G.
        • et al.
        Adjuvant radiation therapy and chemotherapy in Merkel cell carcinoma: survival analyses of 6908 cases from the National Cancer Data Base.
        J Natl Cancer Inst. 2016; 108: 1-9https://doi.org/10.1093/jnci/djw042
        • Chen M.M.
        • Roman S.A.
        • Sosa J.A.
        • Judson B.L.
        The role of adjuvant therapy in the management of head and neck Merkel cell carcinoma.
        JAMA Otolaryngol Neck Surg. 2015; 141: 137https://doi.org/10.1001/jamaoto.2014.3052
        • Leoncini E.
        • Ricciardi W.
        • Cadoni G.
        • et al.
        Adult height and head and neck cancer: a pooled analysis within the INHANCE Consortium.
        Head Neck. 2014; 36: 1391https://doi.org/10.1002/HED
        • Eich H.T.
        • Eich D.
        • Staar S.
        • et al.
        Role of postoperative radiotherapy in the management of Merkel cell carcinoma.
        Am J Clin Oncol Clin Trials. 2002; 25: 50-56https://doi.org/10.1097/00000421-200202000-00011
        • Fields R.C.
        • Busam K.J.
        • Chou J.F.
        • et al.
        Recurrence after complete resection and selective use of adjuvant therapy for stage I through III Merkel cell carcinoma.
        Cancer. 2012; 118: 3311-3320https://doi.org/10.1002/cncr.26626
        • Ghadjar P.
        • Kaanders J.H.
        • Poortmans P.
        • et al.
        The essential role of radiotherapy in the treatment of Merkel cell carcinoma: a study from the rare cancer network.
        Int J Radiat Oncol Biol Phys. 2011; 81: 583-591https://doi.org/10.1016/j.ijrobp.2011.05.028
        • Takes R.P.
        • Balm A.J.
        • Loftus B.M.
        • Baris G.
        • Hilgers F.J.
        • Gregor R.T.
        Merkel cell carcinoma of the head and neck.
        Clin Otolaryngol Allied Sci. 1994; 19: 222-229https://doi.org/10.1002/hed.21787
        • Howle J.R.
        • Hughes T.M.
        • Gebski V.
        • Veness M.J.
        Merkel cell carcinoma: an Australian perspective and the importance of addressing the regional lymph nodes in clinically node-negative patients.
        J Am Acad Dermatol. 2012; 67: 33-40https://doi.org/10.1016/j.jaad.2011.07.029
        • Jabbour J.
        • Cumming R.
        • Scolyer R.A.
        • Hruby G.
        • Thompson J.F.
        • Lee S.
        Merkel cell carcinoma: assessing the effect of wide local excision, lymph node dissection, and radiotherapy on recurrence and survival in early-stage disease – results from a review of 82 consecutive cases diagnosed between 1992 and 2004.
        Ann Surg Oncol. 2007; 14: 1943-1952https://doi.org/10.1245/s10434-006-9327-y
        • Jouary T.
        • Leyral C.
        • Dreno B.
        • et al.
        Adjuvant prophylactic regional radiotherapy versus observation in stage I merkel cell carcinoma: a multicentric prospective randomized study.
        Ann Oncol. 2012; 23: 1074-1080https://doi.org/10.1093/annonc/mdr318
        • Kang S.H.
        • Haydu L.E.
        • Goh R.Y.
        • Fogarty G.B.
        Radiotherapy is associated with significant improvement in local and regional control in Merkel cell carcinoma.
        Radiat Oncol. 2012; 7: 171https://doi.org/10.1186/1748-717X-7-171
        • Meeuwissen J.A.
        • Bourne R.G.
        • Kezarsley J.H.
        The importance of postoperative radiation therapy in the treatment of Merkel cell carcinoma.
        Pergamon l Clin Orig Contrib Int J Radiat Oncol Biol Phys. 1995; 31: 325-331https://doi.org/10.1016/0360-3016(94)E0145-A
        • Mojica P.
        • Smith D.
        • Ellenhorn J.D.I.
        Adjuvant radiation therapy is associated with improved survival in merkel cell carcinoma of the skin.
        J Clin Oncol. 2007; 25: 1043-1047https://doi.org/10.1200/JCO.2006.07.9319
        • Morrison W.H.
        • Peters L.J.
        • Silva E.G.
        • Wendt C.D.
        • Ang K.K.
        • Goepfert H.
        The essential role of radiation therapy in securing locoregional control of Merkel cell carcinoma.
        Int J Radiat Oncol Biol Phys. 1990; 19: 583-591
        • Pectasides D.
        • Papaxoinis G.
        • Pectasides E.
        • et al.
        Merkel cell carcinoma of the skin: a retrospective study of 24 cases by the Hellenic Cooperative Oncology Group.
        Oncology. 2008; 72: 211-218https://doi.org/10.1159/000112944
        • Poulsen M.
        • Round C.
        • Keller J.
        • Tripcony L.
        • Veness M.
        Factors influencing relapse-free survival in Merkel cell carcinoma of the lower limb-a review of 60 cases.
        Int J Radiat Oncol Biol Phys. 2010; 76: 393-397https://doi.org/10.1016/j.ijrobp.2009.02.014
        • Reichgelt B.A.
        • Visser O.
        Epidemiology and survival of Merkel cell carcinoma in the Netherlands. A population-based study of 808 cases in 1993–2007.
        Eur J Cancer. 2011; 47: 579-585https://doi.org/10.1016/j.ejca.2010.11.002
        • Setoyama T.
        • Natsugoe S.
        • Okumura H.
        • et al.
        a-Catenin is a significant prognostic factor than E-cadherin in esophogeal squamous cell carcinoma.
        J Surg Oncol. 2007; 95: 148-155https://doi.org/10.1002/jso
        • Takagishi S.R.
        • Marx T.E.
        • Lewis C.
        • et al.
        Postoperative radiation therapy is associated with a reduced risk of local recurrence among low risk Merkel cell carcinomas of the head and neck.
        Adv Radiat Oncol. 2016; 1: 244-251https://doi.org/10.1016/j.adro.2016.10.003
        • Tarantola T.I.
        • Vallow L.A.
        • Halyard M.Y.
        • et al.
        Prognostic factors in Merkel cell carcinoma: analysis of 240 cases.
        J Am Acad Dermatol. 2013; 68: 425-432https://doi.org/10.1016/j.jaad.2012.09.036
        • Rastrelli M.
        • Ferrazzi B.
        • Cavallin F.
        • et al.
        Prognostic factors in Merkel cell carcinoma: a retrospective single-center study in 90 patients.
        Cancers (Basel). 2018; 10: 350https://doi.org/10.3390/cancers10100350
        • van Veenendaal L.M.
        • van Akkooi A.C.J.
        • Verhoef C.
        • et al.
        Merkel cell carcinoma: clinical outcome and prognostic factors in 351 patients.
        J Surg Oncol. December 2017; 2018: 1768-1775https://doi.org/10.1002/jso.25090
      2. Wazen RM, Kuroda S, Nishio C, Sellin K, Brunski JB, Nanci A. NIH Public Access. 2014;8(9):1385-1395. doi: 10.2217/nnm.12.167.Gene.

        • Lebbe C.
        • Becker J.C.
        • Grob J.J.
        • et al.
        Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline.
        Eur J Cancer. 2015; 51: 2396-2403https://doi.org/10.1016/j.ejca.2015.06.131
        • Tseng Y.D.
        • Apisarnthanarax S.
        • Liao J.J.
        • Bhatia S.
        • Nghiem P.T.
        • Parvathaneni U.
        Factors influencing radiation treatment recommendations in early-stage Merkel cell carcinoma: a survey of US-based radiation oncologists.
        Expert Rev Anticancer Ther. 2017; 17: 281-287https://doi.org/10.1080/14737140.2017.1285233
        • Han A.Y.
        • Patel P.B.
        • Anderson M.
        • Diaz M.F.P.
        • Chin R.
        • St. John M.A.
        Adjuvant radiation therapy improves patient survival in early-stage merkel cell carcinoma: a 15-year single-institution study.
        Laryngoscope. 2018; 128: 1862-1866https://doi.org/10.1002/lary.27031
        • Harrington C.
        • Kwan W.
        Radiotherapy and conservative surgery in the locoregional management of merkel cell carcinoma: the British Columbia Cancer Agency Experience.
        Ann Surg Oncol. 2016; 23: 573-578https://doi.org/10.1245/s10434-015-4812-9
        • Hoeller U.
        • Mueller T.
        • Schubert T.
        • et al.
        Regional nodal relapse in surgically staged Merkel cell carcinoma.
        Strahlenther Onkol. 2015; 191: 51-58https://doi.org/10.1007/s00066-014-0756-4